Sinclair Pharma (XPAR:SPH) Short-Term Capital Lease Obligation : €0.00 Mil (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is Sinclair Pharma Short-Term Capital Lease Obligation?

Sinclair Pharma's Short-Term Capital Lease Obligation for the quarter that ended in Jun. 2018 was €0.00 Mil.

Sinclair Pharma's annual Short-Term Capital Lease Obligation stayed the same from Jun. 2014 (€0.03 Mil) to Jun. 2015 (€0.03 Mil) but then declined from Jun. 2015 (€0.03 Mil) to Dec. 2017 (€0.00 Mil).

Sinclair Pharma Short-Term Capital Lease Obligation Historical Data

The historical data trend for Sinclair Pharma's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma Short-Term Capital Lease Obligation Chart

Sinclair Pharma Annual Data

Trend

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Dec17

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.02

0.03

Sinclair Pharma Semi-Annual Data
	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Jun17	Dec17	Jun18
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	-	-

Sinclair Pharma Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Sinclair Pharma Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinclair Pharma (XPAR:SPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.sinclairispharma.com

Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.